Eye Floaters can be more than a mild nuisance—they often impact a patient’s day-to-day life. Yet discussing treatment options can be challenging. In an expert roundtable by Optometry Today in partnership with ebiga-VISION and VivaQuity, leading professionals shared their clinical experiences and approaches to managing floaters, offering fresh perspectives on this common condition.
Dr. Scott Mackie – Optometrist and owner of Mackie Opticians (Hakim Group, Scotland). With extensive experience in identifying and managing floaters, Dr. Mackie emphasizes the importance of quality-of-life discussions. “Patients often struggle with tasks like night driving due to floaters. As optometrists, we must dig deeper and address these concerns.”
Dr. Frank Eperjesi – Optometrist and co-founder of EyeTools (West Midlands, England). Dr. Eperjesi believes optometrists need to ask more targeted questions about floaters. “We now have options to help patients whose lives are impacted by floaters, beyond just surgery or waiting it out.”
Prof. John M. Nolan – Principal Investigator, Howard Chair in Human Nutrition, Nutrition Research Centre Ireland, South East Technological University (Waterford, Ireland). Prof. Nolan has over 20 years of research into how targeted nutrition can benefit visual health. “Our research helps eye care professionals find alternative, long-term care solutions for patients with floaters.”
Dr. Thomas Kaercher – Ophthalmologist (Heidelberg, Germany). With over a decade of experience treating floaters, Dr. Kaercher believes in providing clear, patient-centered explanations to help them navigate their treatment options. “Patients need proper explanations—this builds trust and encourages adherence to treatment.”
Understanding patient experiences and offering clear, personalized care is essential. From conservative management to innovative research, eye care professionals must provide solutions that enhance quality of life.
The expert panel focuses on the the management of eye floaters and the current research behind VitroCap®N.
VitroCap®N is a micronutrient supplement specifically designed to reduce and dissolve floaters within the vitreous. Backed by five clinical trials confirming its efficacy and safety, VitroCap®N contains a blend of micronutrients, antioxidants, and bioactive compounds scientifically proven to support ocular health. VitroCap®N is the enhanced successor to the original VitroCap® formulation. The recommended dosage is one capsule daily with food for an initial period of at least 3 to 6 months, depending on individual response. Continued use beyond this period should be based on individual needs.
